Lovastatin Tablet
Product Images NDC 43063-939

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 43063-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063939 Label (43063939)

43063939 Label (43063939)
The text seems to describe a medication called Lovastatin produced by b Pharmaceuticals, which comes in doses of 5, 20, and 40 MG. The medication is available in bottles with 30 tablets, and the Reorder number of the product is 110742. It also includes an expiry date of 05/20 and advises users to contact their physician if they experience any side effects. The remaining text seems to contain codes or serial numbers that are difficult to decipher, and the words are not legible.*
FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
This appears to be a figure in a medical research paper showing the proportion of participants without acute major coronary events over years of follow-up. The primary endpoint is likely to be the occurrence of such events. No other details or data are available in this text.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
This document provides a table of drugs and their associated interactions that can increase the risk of myopathy or rhabdomyolysis. The prescribing recommendations for the drug interactions are also included in the table. Strong CYP3A4 inhibitors, HIV protease inhibitors, and Cobicistat-containing products are contraindicated with lovastatin, whereas Gemfibrozil should be avoided with lovastatin. Cyclosporine, Danazol, Difiazem, and Dronedarone should not be exceeded beyond a certain daily dose of lovastatin. Additionally, grapefruit juice should be avoided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.